GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (OTCPK:SHPMY) » Definitions » Shiller PE Ratio

Shanghai Pharmaceuticals Holding Co (Shanghai Pharmaceuticals Holding Co) Shiller PE Ratio : 11.94 (As of May. 08, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co Shiller PE Ratio?

As of today (2024-05-08), Shanghai Pharmaceuticals Holding Co's current share price is $7.40. Shanghai Pharmaceuticals Holding Co's E10 for the quarter that ended in Mar. 2024 was $0.62. Shanghai Pharmaceuticals Holding Co's Shiller PE Ratio for today is 11.94.

The historical rank and industry rank for Shanghai Pharmaceuticals Holding Co's Shiller PE Ratio or its related term are showing as below:

SHPMY' s Shiller PE Ratio Range Over the Past 10 Years
Min: 11.21   Med: 19.74   Max: 52.63
Current: 13.21

During the past years, Shanghai Pharmaceuticals Holding Co's highest Shiller PE Ratio was 52.63. The lowest was 11.21. And the median was 19.74.

SHPMY's Shiller PE Ratio is ranked better than
81.48% of 54 companies
in the Medical Distribution industry
Industry Median: 20.085 vs SHPMY: 13.21

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Shanghai Pharmaceuticals Holding Co's adjusted earnings per share data for the three months ended in Mar. 2024 was $0.292. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $0.62 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shanghai Pharmaceuticals Holding Co Shiller PE Ratio Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co Shiller PE Ratio Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.71 15.49 14.93 12.53 11.78

Shanghai Pharmaceuticals Holding Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.18 15.63 12.43 11.78 11.78

Competitive Comparison of Shanghai Pharmaceuticals Holding Co's Shiller PE Ratio

For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Pharmaceuticals Holding Co's Shiller PE Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's Shiller PE Ratio falls into.



Shanghai Pharmaceuticals Holding Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Shanghai Pharmaceuticals Holding Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=7.40/0.62
=11.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Pharmaceuticals Holding Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Shanghai Pharmaceuticals Holding Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.292/114.6694*114.6694
=0.292

Current CPI (Mar. 2024) = 114.6694.

Shanghai Pharmaceuticals Holding Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.218 98.200 0.255
201409 0.180 98.900 0.209
201412 0.204 99.000 0.236
201503 0.219 99.900 0.251
201506 0.240 99.500 0.277
201509 0.188 100.500 0.215
201512 0.201 100.600 0.229
201603 0.254 102.200 0.285
201606 0.238 101.400 0.269
201609 0.202 102.400 0.226
201612 0.199 102.600 0.222
201703 0.270 103.200 0.300
201706 0.253 103.100 0.281
201709 0.216 104.100 0.238
201712 0.235 104.500 0.258
201803 0.289 105.300 0.315
201806 0.276 104.900 0.302
201809 0.346 106.600 0.372
201812 0.128 106.500 0.138
201903 0.298 107.700 0.317
201906 0.290 107.700 0.309
201909 0.274 109.800 0.286
201912 0.171 111.200 0.176
202003 0.264 112.300 0.270
202006 0.346 110.400 0.359
202009 0.301 111.700 0.309
202012 0.237 111.500 0.244
202103 0.576 112.662 0.586
202106 0.397 111.769 0.407
202109 0.248 112.215 0.253
202112 0.165 113.108 0.167
202203 0.347 114.335 0.348
202206 0.515 114.558 0.516
202209 0.228 115.339 0.227
202212 0.115 115.116 0.115
202303 0.297 115.116 0.296
202306 0.209 114.558 0.209
202309 0.219 115.339 0.218
202312 -0.007 114.669 -0.007
202403 0.292 114.669 0.292

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shanghai Pharmaceuticals Holding Co  (OTCPK:SHPMY) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Shanghai Pharmaceuticals Holding Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Pharmaceuticals Holding Co (Shanghai Pharmaceuticals Holding Co) Business Description

Address
No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding is a vertically integrated Chinese healthcare company that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the second-largest distributor by revenue and has a strong distribution presence in Eastern China.